Guidelines for hematologists
For guidance regarding COVID-19, see FAQ by the EHA SWG on Infections
EHA creates clinical practice guidelines for diagnosis and treatment of hematologic diseases. This initiative started in 2019 with the establishment of a Guidelines Committee and the definition the EHA Methodology for guidelines. Since then, in addition to developing its own guidelines, EHA has established a framework for collaboration with ESMO (European Society for Medical Oncology) to produce guidelines on hematologic malignancies.
The Guidelines Committee has approved the following methodology documents:
For guidance regarding COVID-19, see FAQ by the EHA SWG on Infections
EHA Guidelines by topic
- Bleeding disorders
Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report - CMML
Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults
Guidelines produced by other societies and endorsed by EHA
Upcoming EHA Guidelines
- Management of anti-thrombotic treatment in thrombocytopenic patients
- Anticoagulant and anti-platelet treatment in patients with inherited bleeding disorders
- Management of Pregnancy in Rare Inherited Anemias
Last Updated on Tuesday 19 July 2022.
Back